Sources

*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.

*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.

*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.

*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.

¹ Nearly 1 in 6 of world’s population suffer from neurological disorders – UN report. UN News Center: 27 Feb. 2007. reviewed 10/30/16

² Mental Health Action Plan. WHO: 2013, Page 8, paragraph 1. Reviewed 10/30/16

³ WHO Media Center Fact Sheet No. 307. WHO: 2013. Reviewed 10/30/16

¹Baker M.G., Kale R., Menken M. The wall between neurology and psychiatry. BMJ. 2002 Jun 22; 324(7352): 1468–1469. [Internet] Accessed Jan 2017.

²McGovern Institute. Brain Disorders by the Numbers. [Internet]. Accessed Oct 2016.

³Hirsch L, et al, The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis. Neuroepidemiology 2016;46:292-300. [Internet] Accessed Jan 2017.

⁴Parkinson Association of the Carolinas, Statistics on Parkinson’s Disease. [Internet] Accessed Nov. 15, 2016.

⁵Chen S-Y, Tsai S-T, The Epidemiology of Parkinson’s Disease. Tzu Chi Medical Journal, V22, Issue 2, 2010 Jun; 73-81. [Internet] Accessed Jan 2017

¹Swann A.C. Long-term treatment in bipolar disorder. Journal of Clinical Psychiatry. 2005; 66(1):7–12.

²National Institute of Mental Health. Bipolar Disorder. [Internet]. Accessed March 17, 2016.

³ “Bipolar Disorder.” Decision Resources. Table 2-2. Burlington, MA. December 2013.

⁴National Alliance on Mental Illness. The Impact and Cost of Mental Illness: The Case of Bipolar Disorder. [Internet]. Accessed March 17, 2016.

⁵ National Alliance on Mental Illness. A Primer on Depressive, Bipolar and Anxiety Illnesses: Facts for Policymakers. [Internet]. Accessed March 17, 2016.

⁶American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000.

⁷ The Depression and Bipolar Support Alliance. Mood Disorders and Different Kinds of Depression. [Internet]. Accessed March 17, 2016.

⁸Huxley N., Baldisseri R.J., Disability and its Treatment in Bipolar Disorder Patients. Bipolar Disorder. 2007; 9(1-2):183-96.

⁹Calabrese J.R., Hirschfeld R.M., Frye M.A., Reed M.L. Impact Of Depressive Symptoms Compared with Manic Symptoms in Bipolar Disorder: Results of a U.S. Community-Based Sample. Journal of Clinical Psychiatry. 2004; 65(11):1499-504.

¹⁰Parker G., McCraw S., Hadzi-Pavlovic D., Fletcher K. Costs Incurred By Those With Bipolar I, BipolarII And Unipolar Disorders. Journal of Affective Disorders. 2012; 149(1-3):46-55. (ePub).

¹¹Leverich G.S., Altshuler L.L., Frye M.A., et al. Factors Associated With Suicide Attempts In 648 Patients With Bipolar Disorder In The Stanley Foundation Bipolar Network. Journal of Clinical Psychiatry. 2003; 64(5):506-15.

¹²National Alliance on Mental Illness. Bipolar Disorder. [Internet]. Accessed November 2016.

³World Health Organization. Schizophrenia. [Internet]. Accessed November 2016.

⁴National Institute of Mental Health. Schizophrenia. [Internet]. Accessed November 2016.

¹Institute of Medicine (IOM). 2012. “Epilepsy across the spectrum: Promoting health and understanding.” Washington, DC: The National Academies Press.

²National Institutes of Health. “NINDS Epilepsy Information Page” Accessed July 2015.

³Epilepsy Foundation. “Complex Partial Seizures.” Accessed July 2015.

⁴Brodie M.J., Barry S.J.E., Bamagous G.A., Norrie J.D., Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012;78:1548-1554.

⁵Kwan P., Brodie M.J. “Early Identification of Refractory Epilepsy.” New England Journal of Medicine (2000): 342(5):314-9.

⁶Epilepsy Foundation. “If First Medicine Doesn’t Work”. Accessed November 2016.

¹Denny 1999 J Neurolog Sci, v165, p18-23, table 3.

²Schrag 2000 Brain v123, p2297-2305.

³Parkinson Association of the Carolinas, Statistics on Parkinson’s Disease. [Internet] Accessed November 15, 2016.

⁴Parkinson Disease Foundation, Statistics on Parkinson’s. [Internet] Accessed Jan. 2017.

¹Respiratory Diseases in the World: Realities of Today – Opportunities for Tomorrow. Forum of International Respiratory Societies: 2013. Accessed October 2016.

²About Chronic Respiratory Diseases. World Health Organization. Accessed October 2016

³National Heart, Lung and Blood Institute. What is COPD? [Internet]. Accessed November 2016.

¹National Heart, Lung and Blood Institute. What is COPD? [Internet]. Accessed November 2016.

²Centers for Disease Control and Prevention: Morbidity and Mortality Weekly Report (MMWR). Employment and Activity Limitations Among Adults with Chronic Obstructive Pulmonary Disease — United States, 2013. March 27, 2015; 64(11). [Internet]. Accessed November 2016.

³Centers for Disease Control and Prevention. Chronic Obstructive Pulmonary Disease (COPD). [Internet] Accessed October 2016.

⁴World Health Organization. Burden of COPD. [Internet] Accessed October 2016.

*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.